Depressive and anxiety disorder comorbidity in obsessive compulsive disorderBHATTACHARYYA, Sagnik; JANARDHAN REDDY, Y. C; KHANNA, S et al.Psychopathology. 2005, Vol 38, Num 6, pp 315-319, issn 0254-4962, 5 p.Article

Glutamatergic dysfunction in OCDCHAKRABARTY, Kaushik; BHATTACHARYYA, Sagnik; CHRISTOPHER, Rita et al.Neuropsychopharmacology (New York, NY). 2005, Vol 30, Num 9, pp 1735-1740, issn 0893-133X, 6 p.Article

Dhat Syndrome: A Systematic ReviewUDINA, Marc; FOULON, Hubert; VALDES, Manuel et al.Psychosomatics (Washington, DC). 2013, Vol 54, Num 3, pp 212-218, issn 0033-3182, 7 p.Article

Anti-Brain Autoantibodies and Altered Excitatory Neurotransmitters in Obsessive-Compulsive DisorderBHATTACHARYYA, Sagnik; KHANNA, Sumant; CHAKRABARTY, Koushik et al.Neuropsychopharmacology (New York, NY). 2009, Vol 34, Num 12, pp 2489-2496, issn 0893-133X, 8 p.Article

Opposite Effects of Δ-9-Tetrahydrocannabinol and Cannabidiol on Human Brain Function and PsychopathologyBHATTACHARYYA, Sagnik; MORRISON, Paul D; MEHTA, Mitul A et al.Neuropsychopharmacology (New York, NY). 2010, Vol 35, Num 3, pp 764-774, issn 0893-133X, 11 p.Article

Road work on memory lane-Functional and structural alterations to the learning and memory circuit in adults born very pretermSALVAN, Piergiorgio; WALSH, Seán Froudist; ALLIN, Matthew P. G et al.NeuroImage (Orlando, Fla.). 2014, Vol 102, pp 152-161, issn 1053-8119, 10 p., 1Article

Disruption of Frontal Theta Coherence by Δ⁹-Tetrahydrocannabinol is Associated with Positive Psychotic SymptomsMORRISON, Paul D; NOTTAGE, Judith; MURRAY, Robin M et al.Neuropsychopharmacology (New York, NY). 2011, Vol 36, Num 4, pp 827-836, issn 0893-133X, 10 p.Article

Neural Mechanisms for the Cannabinoid Modulation of Cognition and Affect in Man: A Critical Review of Neuroimaging StudiesBHATTACHARYYA, Sagnik; ATAKAN, Zerrin; MARTIN-SANTOS, Rocio et al.Current pharmaceutical design (Print). 2012, Vol 18, Num 32, pp 5045-5054, issn 1381-6128, 10 p.Article

Effect of BDNF val⁶⁶met polymorphism on declarative memory and its neural substrate: A meta-analysisKAMBEITZ, Joseph P; BHATTACHARYYA, Sagnik; KAMBEITZ-ILANKOVIC, Lana M et al.Neuroscience and biobehavioral reviews. 2012, Vol 36, Num 9, pp 2165-2177, issn 0149-7634, 13 p.Article

Neural basis of anxiolytic effects of cannabidiol (CBD) in generalized social anxiety disorder: a preliminary reportCRIPPA, José Alexandre S; NOGUEIRA DERENUSSON, Guilherme; SANTOS, Alaor et al.Journal of psychopharmacology (Oxford). 2011, Vol 25, Num 1, pp 121-130, issn 0269-8811, 10 p.Article

Induction of Psychosis by Δ9-Tetrahydrocannabinol Reflects Modulation of Prefrontal and Striatal Function During Attentional Salience ProcessingBHATTACHARYYA, Sagnik; CRIPPA, Jose Alexandre; GIAMPIETRO, Vincent et al.Archives of general psychiatry. 2012, Vol 69, Num 1, pp 27-36, issn 0003-990X, 10 p.Article

Alterations in White Matter Evident Before the Onset of PsychosisCARLETTI, Francesco; WOOLLEY, James B; WILLIAMS, Steve C. R et al.Schizophrenia bulletin. 2012, Vol 38, Num 6, pp 1170-1179, issn 0586-7614, 10 p.Article

Modulation of Mediotemporal and Ventrostriatal Function in Humans by A9-Tetrahydrocannabinol : A Neural Basis for the Effects of Cannabis sativa on Learning and PsychosisBHATTACHARYYA, Sagnik; FUSAR-POLI, Paolo; GIAMPIETRO, Vincent et al.Archives of general psychiatry. 2009, Vol 66, Num 4, pp 442-451, issn 0003-990X, 10 p.Article

Anti-depressive therapies after heart transplantationFUSAR-POLI, Paolo; PICCHIONI, Marco; MARTINELLI, Valentina et al.The Journal of heart and lung transplantation. 2006, Vol 25, Num 7, pp 785-793, issn 1053-2498, 9 p.Article

Role of the endocannabinoid system in brain functions relevant for schizophrenia: An overview of human challenge studies with cannabis or Δ9-tetrahydrocannabinol (THC)BOSSONG, Matthijs G; JANSMA, J. Martijn; BHATTACHARYYA, Sagnik et al.Progress in neuro-psychopharmacology & biological psychiatry. 2014, Vol 52, pp 53-69, issn 0278-5846, 17 p.Conference Paper

Presynaptic Striatal Dopamine Dysfunction in People at Ultra-high Risk for Psychosis: Findings in a Second CohortEGERTON, Alice; CHADDOCK, Christopher A; WINTON-BROWN, Toby T et al.Biological psychiatry (1969). 2013, Vol 74, Num 2, pp 106-112, issn 0006-3223, 7 p.Article

A Critical Review of the Antipsychotic Effects of Cannabidiol: 30 Years of a Translational InvestigationZUARDI, Antonio Waldo; CRIPPA, Jose Alexandre S; HALLAK, Jaime E. C et al.Current pharmaceutical design (Print). 2012, Vol 18, Num 32, pp 5131-5140, issn 1381-6128, 10 p.Article

Altered Medial Temporal Activation Related to Local Glutamate Levels in Subjects with Prodromal Signs of PsychosisVALLI, Isabel; STONE, James; MCGUIRE, Philip et al.Biological psychiatry (1969). 2011, Vol 69, Num 1, pp 97-99, issn 0006-3223, 3 p.Article

Distinct Effects of A9-Tetrahydrocannabinol and Cannabidiol on Neural Activation During Emotional ProcessingFUSAR-POLI, Paolo; CRIPPA, José A; ZUARDI, Antonio W et al.Archives of general psychiatry. 2009, Vol 66, Num 1, pp 95-105, issn 0003-990X, 11 p.Article

Neural Basis of A-9-Tetrahydrocannabinol and Cannabidiol : Effects During Response InhibitionBORGWARDT, Stefan J; ALLEN, Paul; RUBIA, Katya et al.Biological psychiatry (1969). 2008, Vol 64, Num 11, pp 966-973, issn 0006-3223, 8 p.Article